BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9802062)

  • 1. Replication-dependent and -independent camptothecin cytotoxicity of seven human colon tumor cell lines.
    Borovitskaya AE; D'Arpa P
    Oncol Res; 1998; 10(5):271-6. PubMed ID: 9802062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
    Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
    Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen.
    Goldwasser F; Bae I; Valenti M; Torres K; Pommier Y
    Cancer Res; 1995 May; 55(10):2116-21. PubMed ID: 7743511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
    Hsiang YH; Lihou MG; Liu LF
    Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy between the initial DNA damage and cell survival after camptothecin treatment in two murine lymphoma L5178Y sublines.
    Gradzka I; Szumiel I
    Cell Biochem Funct; 1996 Sep; 14(3):163-71. PubMed ID: 8888569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of DNA replication in extracts of camptothecin-treated cells: activation of an S-phase checkpoint?
    Wang Y; Perrault AR; Iliakis G
    Cancer Res; 1997 May; 57(9):1654-9. PubMed ID: 9135002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.
    Chang JY; Liu JF; Juang SH; Liu TW; Chen LT
    Cancer Res; 2002 Jul; 62(13):3716-21. PubMed ID: 12097280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
    Zhou Y; Gwadry FG; Reinhold WC; Miller LD; Smith LH; Scherf U; Liu ET; Kohn KW; Pommier Y; Weinstein JN
    Cancer Res; 2002 Mar; 62(6):1688-95. PubMed ID: 11912141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines.
    Beidler DR; Chang JY; Zhou BS; Cheng YC
    Cancer Res; 1996 Jan; 56(2):345-53. PubMed ID: 8542590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
    Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y
    Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair.
    Fujimori A; Gupta M; Hoki Y; Pommier Y
    Mol Pharmacol; 1996 Dec; 50(6):1472-8. PubMed ID: 8967967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.
    Sané AT; Bertrand R
    Cancer Res; 1999 Aug; 59(15):3565-9. PubMed ID: 10446962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.
    Tsao YP; Russo A; Nyamuswa G; Silber R; Liu LF
    Cancer Res; 1993 Dec; 53(24):5908-14. PubMed ID: 8261402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 7-alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified mammalian topoisomerase I and in human colon carcinoma SW620 cells.
    Valenti M; Nieves-Neira W; Kohlhagen G; Kohn KW; Wall ME; Wani MC; Pommier Y
    Mol Pharmacol; 1997 Jul; 52(1):82-7. PubMed ID: 9224816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.
    Beidler DR; Cheng YC
    Mol Pharmacol; 1995 May; 47(5):907-14. PubMed ID: 7538195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin.
    Desai SD; Liu LF; Vazquez-Abad D; D'Arpa P
    J Biol Chem; 1997 Sep; 272(39):24159-64. PubMed ID: 9305865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase I content of a pair of human melanoma cell lines with very different radiosensitivities correlates with their in vitro sensitivities to camptothecin.
    Ng CE; Cybulski SE; Bussey AM; Aubin RA; Raaphorst GP
    Anticancer Res; 1998; 18(4C):3119-26. PubMed ID: 9713520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camptothecin induces DNA strand breaks and is cytotoxic in stimulated normal lymphocytes.
    Yamauchi T; Yoshida A; Ueda T
    Oncol Rep; 2011 Feb; 25(2):347-52. PubMed ID: 21165573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.